Market

Goldman Sachs initiates coverage on ORIC stock with Early-Stage Biotech rating

Goldman Sachs initiates coverage on ORIC stock with Early-Stage Biotech rating
Read More

Related Posts

RBA to hold in December, outlook shifts to long hold through 2026- Reuters poll

RBA to hold in December, outlook shifts to long hold th...

Commercial Metals stock rating upgraded by JPMorgan on tariff benefits

Commercial Metals stock rating upgraded by JPMorgan on ...

Evercore ISI reiterates Outperform rating on Samsara stock amid NNARR growth

Evercore ISI reiterates Outperform rating on Samsara st...

HP Enterprise stock outperforms despite revenue miss, Evercore maintains rating

HP Enterprise stock outperforms despite revenue miss, E...

SoFi prices $1.5 billion public offering of common stock

SoFi prices $1.5 billion public offering of common stock

Macy’s stock price target raised to $21 from $14 at Evercore ISI

Macy’s stock price target raised to $21 from $14 at Eve...